Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies

Autor: Burgos-Vargas, Ruben, Cardiel, Mario, Xibillèc), Daniel, Pacheco-Tena, Cèc)sar, Pascual-Ramos, Virginia, Abud-Mendoza, Carlos, Mahgoub, Ehab, Rahman, Mahboob, Fan, Haiyun, Rojo, Ricardo, García, Erika, Santana, Karina
Zdroj: In Reumatología clínica (English Edition) January-February 2019 15(1):43-53
Databáze: ScienceDirect
Externí odkaz: